Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd

Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Monday, October 2, 2023
Exercise, Attention, Therapy, The Women on the 6th Floor, Capital market, Oppenheimer, Telephone, Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd, Sale, Prospectus, Form S-3, Form, Madison Avenue, Security (finance), Rare, Guggenheim Partners

The gross proceeds of the public offering were $69.0 million, before deducting the underwriting discount and other estimated offering expenses.

Key Points: 
  • The gross proceeds of the public offering were $69.0 million, before deducting the underwriting discount and other estimated offering expenses.
  • Guggenheim Securities, LLC, Cantor Fitzgerald & Co., and Oppenheimer & Co. Inc. acted as the joint book-running managers for the public offering and placement agents for the concurrent private placement.
  • Laidlaw & Company (UK) Ltd. acted as lead manager for the offering and a placement agent for the concurrent private placement.
  • The securities described above relating to the public offering were offered by Soleno pursuant to registration statements on Form S-3 (File Nos.

Tresorfx Launches Revolutionary UK Investment Service: Investing UK

Retrieved on: 
Friday, January 20, 2023
Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd, Risk, Investment, Financial services

London, United Kingdom--(Newsfile Corp. - January 20, 2023) - Tresorfx, a leading provider of financial services, is proud to announce the launch of its revolutionary new investment service: Investing UK.

Key Points: 
  • London, United Kingdom--(Newsfile Corp. - January 20, 2023) - Tresorfx, a leading provider of financial services, is proud to announce the launch of its revolutionary new investment service: Investing UK.
  • Investing UK is built on Tresorfx's commitment to providing its clients with the best possible investment experience.
  • "We are thrilled to be launching Investing UK, which we believe will be a game-changer for investors looking to tap into the UK's vast investment potential," said Clyde Ritterstrom, CEO of Tresorfx.
  • Investing UK offers a range of investment options, including stocks, bonds, real estate, and private equity, allowing clients to diversify their portfolios and reduce risk.

James Ahern of Laidlaw Venture Partners Joins with Naples Redevelopment Group on New Real Estate Project

Retrieved on: 
Tuesday, December 13, 2022
MHK, Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd, The Mark, LVP, Laidlaw, Restaurant, Research, Financial services

NEW YORK, Dec. 13, 2022 /PRNewswire/ -- Laidlaw Venture Partners, aprivate equity financing and accelerating arm of Laidlaw & Company (UK) Ltd., is pleased to announce their participation ina new real estate project in Naples, Florida, "The Mark on 8th."

Key Points: 
  • NEW YORK, Dec. 13, 2022 /PRNewswire/ -- Laidlaw Venture Partners, aprivate equity financing and accelerating arm of Laidlaw & Company (UK) Ltd., is pleased to announce their participation ina new real estate project in Naples, Florida, "The Mark on 8th."
  • The project has been designed by Naples' locally renowned architecture firm MHK.
  • Founder of Laidlaw Venture Partners, James Ahern stated: "These 24 contemporary, luxury condominiums will contribute a beautiful addition to the already charming streets of Naples.
  • Laidlaw Venture Partners (LVP) is the venture capital arm of Laidlaw Private Equity.

Cingulate Inc. Announces Closing of Initial Public Offering

Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd, U.S. Securities and Exchange Commission, Technology, Time, Form, Nature, ADHD, Dextroamphetamine, Forward-looking statement, Telephone, Security (finance), Seventh Avenue, Nasdaq, Patient, Sale, Prospectus, GLOBE, Attention deficit hyperactivity disorder, Risk, Private Securities Litigation Reform Act, Precision Time Protocol, Research, Exercise, SEC, Attention, Public expenditure, Cingulate cortex, PTR

Gross proceeds for the offering were approximately$25.0 million, before underwriting discounts and commissions and estimated offering expenses.

Key Points: 
  • Gross proceeds for the offering were approximately$25.0 million, before underwriting discounts and commissions and estimated offering expenses.
  • The Company granted the underwriters a 45-day over-allotment option to purchase up to an additional 624,999 shares of common stock and/or warrants to purchase up to an additional 624,999 shares of common stock at the initial public offering price.
  • Aegis Capital Corp. acted as lead book-running manager and Laidlaw & Company (UK) Ltd. acted as co-bookrunning manager for the offering.
  • With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates.

aTyr Pharma Announces Closing of $86.3 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Monday, September 20, 2021
Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd, Exercise, RNA transfection, Syndicate, Security (finance), Form S-3, RBC Capital Markets, Sale, LIFE, Attention, U.S. Securities and Exchange Commission, ATyr Pharma, Biology, Form, LLC, SAN, Research, Minnesota, Telephone, Prospectus, Nicollet Mall, SEC, Vesey Street, GLOBE

The gross proceeds to aTyr from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are $86.3 million.

Key Points: 
  • The gross proceeds to aTyr from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are $86.3 million.
  • All of the shares sold in the offering were sold by aTyr.
  • Piper Sandler and RBC Capital Markets acted as joint book-running managers for the offering.
  • The offering was made pursuant effective registration statements, filed by aTyr with the Securities and Exchange Commission ("SEC").